Decoding Regeneron Pharmaceuticals's Options Activity: What's the Big Picture?
Portfolio Pulse from Benzinga Insights
Investors have shown a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with options activity indicating a split sentiment of 37% bullish and 62% bearish. Significant trading activity suggests a price target range of $620 to $980 over the next three months. Current trading volume is 92,111 with a slight price increase of 0.14%, and the stock is potentially approaching overbought territory. Analysts have set an average target price of $1075.25, with varying ratings from Outperform to Neutral.
March 01, 2024 | 4:47 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bearish options activity on REGN with a significant trading range of $620-$980. Current market status shows a slight increase in price, with potential overbought signals. Analysts have a positive outlook with an average target price of $1075.25.
The bearish sentiment from options traders, combined with the current market status and analyst ratings, suggests a cautious but potentially positive outlook for REGN. The significant options activity and the analyst target price indicate investor interest and expectations for future performance. However, the potential overbought signals could temper short-term gains.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100